Based on the Mesa Laboratories Inc stock forecast from 1 analysts, the average analyst target price for Mesa Laboratories Inc is USD 150.00 over the next 12 months. Mesa Laboratories Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Mesa Laboratories Inc is Slightly Bearish, which is based on 5 positive signals and 9 negative signals. At the last closing, Mesa Laboratories Inc’s stock price was USD 114.57. Mesa Laboratories Inc’s stock price has changed by +6.08% over the past week, -6.34% over the past month and +9.10% over the last year.
No recent analyst target price found for Mesa Laboratories Inc
No recent average analyst rating found for Mesa Laboratories Inc
Company Overview Mesa Laboratories Inc
Mesa Laboratories, Inc. develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries. This segment also provides testing and laboratory services to the dental and pharmaceutical industries. The Clinical Genomics segment offers MassARRAY, a genetic analysis tool system, and related consumables, including chips, panels, and chemical reagent solutions used by clinical labs to analyze DNA samples for inherited genetic disease testing, pharmacogenetics, oncology testing, infectious disease testing, doping and toxicology testing, and other differentiated applications for use in research. The Biopharmaceutical Development segment provides automated systems, such as Gyrolab xPand and Gyrolab xPlore hardware and software, Gyrolab Bioaffy consumable microfluidic disks, Gyrolab kits and Rexxip buffers for protein analysis; PurePep Chorus and Symphony instruments for peptide synthesis; and PurePep EasyClean products for purifying peptides. The Calibration Solutions segment offers quality control products to measure and calibrate critical parameters in applications, such as environmental and process monitoring, dialysis, gas flow, air quality, and torque testing in medical device and pharmaceutical manufacturing, laboratory, and hospital environments. This segment's products include continuous monitoring systems, dialysate meters and consumables, data loggers, gas flow calibration and air sampling equipment, and torque testing systems, offered under DialyGuard, ViewPoint, DataTrace, DryCal, and BGI brands. The company was incorporated in 1982 and is headquartered in Lakewood, Colorado. Read Less
Mesa Laboratories, Inc. develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemic...Read More
Frequently Asked Questions About Mesa Laboratories Inc (MLAB) Stock
Based on ratings from 1 analysts Mesa Laboratories Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Slightly Bearish. The stock has 1 buy, sell and hold ratings.
MLAB stock's dividend yield is 0.54%.
Our analysis grades MLAB stock's dividend yield at F. This means that MLAB stock's dividend yield is above 25% of the stocks in the Scientific & Technical Instruments sector in the NSD exchange.
Based on this MLAB may be a poor dividend stock for its sector.
Based on targets from 1 analysts, the average taret price for MLAB is USD 150.00 over the next 12 months. The maximum analyst target price is USD 150 while the minimum anlayst target price is USD 150.
MLAB stock's Price/Earning ratio is 656.71.
Our analysis grades MLAB stock's Price / Earning ratio at F. This means that MLAB stock's Price/Earning ratio is above 91% of the stocks in the Scientific & Technical Instruments sector in the NSD exchange.
Based on this MLAB may be a overvalued for its sector.
The last closing price of MLAB's stock was USD 114.57.
The most recent market capitalization for MLAB is USD 0.65B.
Based on targets from 1 analysts, the average taret price for MLAB is projected at USD 150.00 over the next 12 months.
This means that MLAB's stock price may go up by +30.92% over the next 12 months.
We can't find any ETFs which contains Mesa Laboratories Inc's stock.
As per our most recent records Mesa Laboratories Inc has 736 Employees.
Mesa Laboratories Inc's registered address is 12100 West Sixth Avenue, Lakewood, CO, United States, 80228.
You can get more information about it from Mesa Laboratories Inc's website at https://www.mesalabs.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Low volatility
The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
Superior Revenue Growth
This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.
Superior Dividend Growth
This stock has shown top quartile dividend growth in the previous 5 years compared to its sector
What not to like
Overpriced compared to book value
The stock is trading high compared to its peers median on a price to book value basis.
Overpriced compared to earnings
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
Below median total returns
The company has under performed its peers on annual average total returns in the past 5 years.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Overpriced on cashflow basis
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Low Earnings Growth
This stock has shown below median earnings growth in the previous 5 years compared to its sector
Highly leveraged
The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.
Overpriced on free cash flow basis
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Frequently Asked Questions About Mesa Laboratories Inc (MLAB) Stock
Based on ratings from 1 analysts Mesa Laboratories Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Slightly Bearish. The stock has 1 buy, sell and hold ratings.
MLAB stock's dividend yield is 0.54%.
Our analysis grades MLAB stock's dividend yield at F. This means that MLAB stock's dividend yield is above 25% of the stocks in the Scientific & Technical Instruments sector in the NSD exchange.
Based on this MLAB may be a poor dividend stock for its sector.
Based on targets from 1 analysts, the average taret price for MLAB is USD 150.00 over the next 12 months. The maximum analyst target price is USD 150 while the minimum anlayst target price is USD 150.
MLAB stock's Price/Earning ratio is 656.71.
Our analysis grades MLAB stock's Price / Earning ratio at F. This means that MLAB stock's Price/Earning ratio is above 91% of the stocks in the Scientific & Technical Instruments sector in the NSD exchange.
Based on this MLAB may be a overvalued for its sector.
The last closing price of MLAB's stock was USD 114.57.
The most recent market capitalization for MLAB is USD 0.65B.
Based on targets from 1 analysts, the average taret price for MLAB is projected at USD 150.00 over the next 12 months.
This means that MLAB's stock price may go up by +30.92% over the next 12 months.
We can't find any ETFs which contains Mesa Laboratories Inc's stock.
As per our most recent records Mesa Laboratories Inc has 736 Employees.
Mesa Laboratories Inc's registered address is 12100 West Sixth Avenue, Lakewood, CO, United States, 80228.
You can get more information about it from Mesa Laboratories Inc's website at https://www.mesalabs.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for MLAB !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
